Dr. Kang (Eric) Ting Professor

Executive Director of IOF
Co-chair of IOF Science Committee
Adjunct Professor, American Dental Association, Forsyth Institute, Boston, USA

Visiting Professor, Taiwan National Yang Ming Chiao Tung University

Dr. Eric Kang Ting is currently an adjunct professor at the ADA (American Dental Association) Forsyth Institute in Cambridge, Massachusetts (www.forsyth.org).

In 2022, Professor Ting was appointed as the Executive Director and a Founding Committee member of the International Orthodontics Foundation (www.iofglobal.org).

During more than 20 years at UCLA, Dr. Ting was an Academic Senate Tenured Professor and the founding chair in the Division of Growth and Development for the Sections of Orthodontics and Pediatric Dentistry.  Clinically, Dr. Ting specialized in treating patients with craniofacial anomalies and has volunteered as an attending in the UCLA craniofacial team for more than 20 years.  Dr. Ting also organized and sponsored dental services for the Wounded Warriors program and their families in collaboration with UCLA “Operation Mend” program. In March 2012, Dr. Ting was honored to be invited by the US Marine Commandant James Amos to the Marine Corps Commandant’s house in Washington, D.C., for his work to help the wounded warriors.

Dr. Ting and his research has also received US Navy’s Appreciation Coin. Dr. Ting donated scholarships to UCLA dental students to conduct craniofacial research.

Besides his teaching and clinical responsibilities in Orthodontics, Dr. Ting has a Google Scholar H-Index of 62 as one of the top three orthodontists in the world.

Ting’s original research has received more than 12,000 citations and has been published in many leading journals, including Nature Communications, Journal of Clinical Investigation, PLOS One, and Biomaterials as the principal author. 

Dr. Ting has served as a PARC AAOF committee member since 2015.  

AAO Recognition Award 2024

Dr. Ting was the first dentist scientist as one of the principal investigators for the National Aeronautics and Space Administration (NASA) International Space Station (ISS) RR 5 project. This was the space station’s first successful long-term drug trial in a rodent model. In 2018, Professor Ting and his team received the International Space Station (ISS) Innovation Award for Biology and Medicine for Development of NELL-1 Bone-Growth Systemic Therapy by the American Astronautical Society. Dr. Ting’s team attended White House National Space Council at the Eisenhower Executive Office Building, White House, Washington DC in 2018.

Dr. Ting has received more than $30M in funding from the U.S. government (NIH, CIRM etc) as a key investigator in his career. Based on his research, two novel biologic drugs are currently in FDA clinical trials for scar reduction and bone regeneration respectively.

In 2018, Professor Ting and his team received the International Space Station (ISS) Innovation Award for Biology and Medicine for Development of NELL-1 Bone-Growth Systemic Therapy by the American Astronautical Society. 

Dr. Ting has received more than $30M in funding from the U.S. government as a key investigator in his career.  Based on his research, two novel biologic drugs are currently in FDA clinical trials for scar reduction and bone regeneration respectively.  

Dr. Eric Kang Ting graduated from the Harvard School of Dental Medicine with Magna Cum Laude and the Gold Award with DMD in 1991, becoming the first Asian ever to obtain those awards.

Professor Ting then earned a Doctor of Medical Science and an orthodontic certificate from Harvard in 1994.